Cytoforge Therapeutics
(CYTOFORGE THERAPEUTICS PRIVATE LIMITED)
Founded in 2025
About Cytoforge Therapeutics
CytoForge Therapeutics develops gene and cell therapy platforms and biotherapeutic products for the treatment of cancer and diseases. The company works on in-vivo CAR-T and CAR-M immunotherapy technologies, vector platforms, protein expression systems, and monoclonal cell line tools to support therapeutic and diagnostic development.
Key Founders and Directors of Cytoforge Therapeutics
Incubators & Accelerators of Cytoforge Therapeutics
Public Links of Cytoforge Therapeutics
Frequently Asked Questions (FAQ)
When was Cytoforge Therapeutics founded?
Cytoforge Therapeutics was founded in the year 2025.
What is the legal name of Cytoforge Therapeutics?
The legal name of Cytoforge Therapeutics is Cytoforge Therapeutics Private Limited.
Who are the founders of Cytoforge Therapeutics?
Cytoforge Therapeutics is founded by Anuja Patnaik, Mahin Amit Vasavada and Umasish Mohanty.
Which Incubators & Accelerators supported Cytoforge Therapeutics?
What are the focus areas of Cytoforge Therapeutics?
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8